BrainCo Secures $2.8 Billion Funding Amid Surging BCI Sector Momentum, Advances Toward IPO

　　【Pharmaceutical Network Industry DynamicsSince the opening of the market in 2026, the brain-computer interface sector has been gaining热度, with market funds showing rapidly increasing confidence in the technology's transition from laboratory to scaled application, while numerous investment institutions are continuously injecting capital into promising companies.
 

Recently, BrainCo, a company in the brain-computer interface field, has completed approximately 2 billion yuan in financing. This round of financing was led by IDG and Walden International, with strategic investors from the industrial chain such as Lens Technology and Will Semiconductor.
 

BrainCo focuses on the research and development of brain-computer interface products and is one of the few companies globally to achieve large-scale mass production. It has already obtained FDA certification in the United States and CE certification in Europe. Its technical approach emphasizes non-invasive brain-computer interfaces, establishing a signal pathway between the brain and external devices to provide solutions for the rehabilitation of people with disabilities and the treatment of brain diseases.
 

According to reports, the company's core product "SuperSensor"BrainCo is able to detect weak brain electrical signals without craniotomy and convert them into neural signals to control external devices. Currently, its products have enabled individuals with physical disabilities to achieve functions such as running and performing high-difficulty movements. The company’s leader stated that within the next 5 to 10 years, they plan to help one million people with physical disabilities regain mobility and assist ten million patients with Alzheimer's disease, autism, and insomnia in their rehabilitation."
 

In fact, BrainCo's 2 billion yuan financing is an inevitable result of the industry cycle, policy dividends, capital enthusiasm, and the company's own development. It marks that China's non-invasive brain-computer interface technology has entered the forefront globally. Notably, as brain-computer interfaces have been included in the "15th Five-Year Plan" for future industries, and seven departments issued special guidelines in 2025, capital is currently accelerating its investment in Chinese companies.
 

According to public information, from January to November 2025, China's brain-computer interface sector completed 24 financing rounds, a year-on-year increase of 30%, with amounts ranging from 10 million yuan to 350 million yuan.
 

In August 2025, Beijing Zhiran Medical Technology Co., Ltd., which focuses on developing a new generation of invasive flexible brain-computer interface platforms, announced the completion of an over 300 million yuan Series A round of financing. The funds raised in this round will mainly be used to accelerate the advancement of new technology research and development and to conduct large-scale clinical trials.
 

In December 2025, Step Medical completed its B+ round of financing, providing strong support for subsequent product iteration and large-scale clinical applications. It is reported that Step Medical focuses on the research and application of minimally invasive implantable brain-computer interface technology and is the second invasive brain-computer interface company to enter the clinical stage after Musk's Neuralink.
 

　　……
 

Overall, since 2025, investment and financing activities in China's brain science and brain-inspired intelligence fields have become increasingly active, covering various subfields such as brain-inspired intelligent chip design, brain-computer interface (BCI) systems, brain disease diagnosis and treatment, and neuromodulation solutions. Among these, brain-computer interface (BCI) has emerged as a particularly popular track, including invasive (Stepwise Medical, VisionBrain BCI), non-invasive, and exoskeleton-integrated approaches.
 

In this regard, the industry believes that, with China's increased investment and policy support in the fields of brain science and brain-computer interfaces, as well as continuous financing by leading companies such as BrainCo, this sector will accelerate into a new phase of technological realization and commercial explosion. At the same time, applications will be realized in the medical field and beyond.
 

　　Disclaimer: In no event shall the information or opinions expressed in this article constitute investment advice to any person.